These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34006238)

  • 1. Time and risk factors for death among smear-positive pulmonary tuberculosis patients in the Health District of commune VI of Bamako, Mali, 2016.
    Ballayira Y; Yanogo PK; Konaté B; Diallo F; Sawadogo B; Antara S; Méda N
    BMC Public Health; 2021 May; 21(1):942. PubMed ID: 34006238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: a retrospective case-control study.
    Djouma FN; Noubom M; Ngomba AV; Donfack H; Kouomboua PS; Saah MA
    Pan Afr Med J; 2015; 22():253. PubMed ID: 26958116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
    Diarra B; Kone M; Togo ACG; Sarro YDS; Cisse AB; Somboro A; Degoga B; Tolofoudie M; Kone B; Sanogo M; Baya B; Kodio O; Maiga M; Belson M; Orsega S; Krit M; Dao S; Maiga II; Murphy RL; Rigouts L; Doumbia S; Diallo S; de Jong BC
    PLoS One; 2018; 13(12):e0208603. PubMed ID: 30540823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study.
    Ramakrishnan J; Sarkar S; Chinnakali P; Lakshminarayanan S; Sahu SK; Reshma A; Knudsen S; Das M; Thekkur P; Venugopal V; Hochberg NS; Salgame P; Horsburgh CR; Ellner J; Roy G
    Indian J Tuberc; 2021 Jan; 68(1):32-39. PubMed ID: 33641849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment.
    Rodrigo T; Casals M; Caminero JA; García-García JM; Jiménez-Fuentes MA; Medina JF; Millet JP; Ruiz-Manzano J; Caylá J;
    PLoS One; 2016; 11(8):e0159925. PubMed ID: 27487189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB.
    Kang'ombe CT; Harries AD; Ito K; Clark T; Nyirenda TE; Aldis W; Nunn PP; Semba RD; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jul; 8(7):829-36. PubMed ID: 15260273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.
    Mabunda TE; Ramalivhana NJ; Dambisya YM
    Afr Health Sci; 2014 Dec; 14(4):849-54. PubMed ID: 25834493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude and treatment outcomes of pulmonary tuberculosis patients in a poor urban slum of Abia State, Nigeria.
    Ogbudebe CL; Izuogu S; Abu CE
    Int J Mycobacteriol; 2016 Jun; 5(2):205-10. PubMed ID: 27242233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinant factors for mortality during treatment among tuberculosis patients: Cox proportional hazards model.
    Abedi S; Moosazadeh M; Afshari M; Charati JY; Nezammahalleh A
    Indian J Tuberc; 2019 Jan; 66(1):39-43. PubMed ID: 30797281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi.
    Harries AD; Nyangulu DS; Kang'ombe C; Ndalama D; Glynn JR; Banda H; Wirima JJ; Salaniponi FM; Liomba G; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 1998; 92(3):343-7. PubMed ID: 9861414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    Nogueira BMF; Rolla VC; Akrami KM; Kiene SM
    PLoS One; 2018; 13(4):e0195409. PubMed ID: 29624603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in overall, smear-negative and HIV-positive TB incidence while smear-positive incidence stays stable in Guinea-Bissau 2004-2011.
    Lemvik G; Rudolf F; Vieira F; Sodemann M; Østergaard L; Rodrigues A; Gomes V; Aaby P; Wejse C
    Trop Med Int Health; 2014 Nov; 19(11):1367-76. PubMed ID: 25145557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
    Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
    Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.